2020 Targeting ALK - From Discovery to Frontline Treatment
6 Views
administrator
07/30/23
In this 'keynote', Dr. Yael Mosse presents on the discovery of ALK aberrations in neuroblastoma, their significance at diagnosis and at relapse, drug development strategies and plans to incorporate ALK inhibitors into frontline therapy with potential joint COG and SIOPEN studies, and germline ALK mutation.
Show more
Facebook Comments
No comments found